History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Cycle for Survival Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment
Our Prostate Nomogram
Our Prostate Nomogram
Our Prostate Nomogram helps physicians and patients decide which treatment will result in the greatest benefit
more

Cancer of the prostate is the most common cancer among American men, and the second leading cause of cancer deaths in men after lung cancer.

Memorial Sloan-Kettering's approach to prostate cancer treatment is based on a dynamic model of prostate cancer, in which physicians define therapeutic goals for each patient at the time of diagnosis and then redefine these goals as the disease unfolds.

In this section, you can find information about our expertise in treating patients with prostate cancer, the services we offer patients with this condition, and prostate cancer research under way here.

  • Our Approach & Expertise
    Memorial Sloan-Kettering is recognized worldwide for its strength in diagnosing and treating prostate cancer.
  • Our Team of Experts
    Information about Memorial Sloan-Kettering's prostate cancer specialists, their education, training, board certifications, current publications, and specific areas of clinical expertise.
  • Overview
    An overview of the prevention, diagnosis, treatment, and research of prostate cancer.
  • Risk Factors
    Any man can develop prostate cancer. Age, race, family history, and diet may increase the risk of developing prostate cancer.
  • Screening
    Memorial Sloan-Kettering is one of the few centers that offers a computer-assisted family history analysis of prostate cancer risk. This section includes our recommended screening guidelines.
  • Symptoms
    Many men with prostate cancer experience no symptoms; the first indication that they may have the disease is often an abnormal finding on a routine screening exam. Others may notice one or more symptoms.
  • Diagnosis
    Two standard screening examinations are the first step in diagnosing prostate cancer, whether or not symptoms are present.
  • Clinical States Treatment Model
    Memorial Sloan-Kettering's physicians develop a fully individualized treatment plan for each patient based on a complete picture of his disease -- the severity of his cancer and the risks it poses, his life expectancy, other medical conditions, lifestyle considerations, and personal preferences.
  • Prostate Cancer Treatment & Investigational Approaches
    Several modes of treatment are employed to treat prostate cancer. These include surgery, systemic therapy, and radiation therapy, as well as delayed treatment or watchful waiting.
  • Our Clinical Trials
    A continually updated listing of Memorial Sloan-Kettering's current clinical trials for prostate cancer.
  • Survivorship & Support
    Over the past two decades, new techniques to diagnose prostate cancer early in its progression have boosted the survival rate for men with all stages of prostate cancer from 67 percent to 92 percent.
  • Patient Stories
    Inspirational stories about four men who have survived prostate cancer.

Related Topics & News
PrintEmail This Page